Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
In vivo
EIP Pharma Announces Presentation of Preclinical Data Demonstrating Effects of p38?…
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Newer Targets
Marathon-running molecule could speed up the race for new neurological treatments
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Phase I
IMV Inc. to Present at Upcoming Investor Conference
Phase III
Kodiak Sciences to Host R&D Day on October 14 in San…
Phase I
Roche Vice Chairman Calls for Long-Term Thinking by Business to Save…
Approval
Marizyme Agrees to Distribute Somahlution’s DuraGraft Products in South America and…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
European Results From Global ETNA-AF Registry Show Low Bleeding and Low…
Deals
Some EpiPen and EpiPen Jr auto-injectors may be difficult to remove…
Commercial
AbbVie Stays Busy While Working to Complete Allergan Acquisition
Commercial
Aridis Pharmaceuticals Appoints Infectious Disease Expert Paul Mendelman, MD as Interim…
Home
Clinical
Phase II
Phase II
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Phase II
CTI BioPharma Announces Outcome From End-of-Phase-2a Meeting With U.S. Food and Drug Administration (FDA) Regarding Pacritinib for Treatment of Myelofibrosis
Biospace News
-
July 18, 2019
Phase II
Ascendis Pharma Announces Filing of Investigational New Drug (IND) Application for Initiation of a Global Phase 2 Trial for TransCon CNP in Children with...
Phase II
InflaRx Reports Additional Analysis of the SHINE Phase IIb Results for IFX-1 in Hidradenitis Suppurativa
Phase II
Mallinckrodt Halts Phase 2B Trial Investigating the Use of Acthar Gel (Repository Corticotropin Injection) in Amyotrophic Lateral Sclerosis (ALS)
Phase II
AzurRx BioPharma Announces Initiation of Phase 2 Clinical Study for MS1819-SD in combination with standard PERT for Cystic Fibrosis Patients with Severe Exocrine Pancreatic...
Phase II
Genmab Announces Positive Topline Results in the Phase II GRIFFIN Study...
Firstwordpharma News
-
July 8, 2019
0
Phase II
Monopar Therapeutics and the Spanish Sarcoma Group (GEIS) Team Up on...
Biospace News
-
July 2, 2019
0
Phase II
Biohaven Enrolls First Patient in Phase 2 Clinical Trial of Rimegepant,...
Biospace News
-
July 1, 2019
0
Phase II
Xeris Pharmaceuticals Doses First Patient in Phase 2 Trial Evaluating Its...
Biospace News
-
June 27, 2019
0
Phase II
Ziopharm Oncology Initiates Phase 2 Trial Evaluating Combination Therapy of Controlled...
Firstwordpharma News
-
June 27, 2019
0
1
2
3
...
16
Page 1 of 16
- Advertisement -
MOST POPULAR
Reviva Pharmaceuticals Announces Successful Completion of Pre-IND Meeting with FDA on...
June 3, 2019
FDA advisory panel votes against Daiichi Sankyo’s blood cancer treatment ...
May 14, 2019
Ethicann Pharmaceuticals Inc. Appoints Director of Drug Development and Medical Advisory...
April 24, 2019
PMZ-1620, an Endothelin-B Agonist, enters Phase III Trial in Patients with...
July 18, 2019
Load more
HOT NEWS
Commercial
Antibe Therapeutics Reports 2019 Year-End Financial and Operating Results
Phase II
TYME and The Joseph Ahmed Foundation Announce Initiation of the HopES...
Acquisitions
Merck Completes Tender Offer to Acquire Immune Design
Commercial
Biohaven Broadens Senior Leadership Team With Veteran Pharma Commercial Experience
